TLRY compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name

TLRYTilray Brands, Inc.

Mkt capRevenueRevenue

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TLRYTilray Brands, Inc.

DFTXDefinium Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TLRY2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 8 '26±9.3%▼−3.36%×0.37

Q1 FY27—▲+5.26%—

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

= impliedTLRY realized, solidDFTX realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedspan: TLRY 70d · DFTX 207dSource: market data

Q1 FY26

±12.9%

▲+0.93%

×0.07

Jan 12 '26—▲+0.29%—

TLRYTilray Brands, Inc.

2.96▲+11.70%· post 2.97

Mkt cap$391.6MRevenue$257MQ1 FY27Revenue$915MFY26

DFTXDefinium Therapeutics, Inc.

32.70▼−2.11%· post 32.38

ClosedNov 4 '26

Mkt cap$4.4BRevenue—Revenue—

Compare

ClosedNov 4 '26

TLRYTilray Brands, Inc.

DFTXDefinium Therapeutics, Inc.

2.96▲+11.70%post 2.97

Price

32.70▼−2.11%post 32.38

$391.6M

Mkt cap

$4.4B

Q1 FY27$257M

Revenue

—

FY26$915M

Revenue

—

TLRY2.96▲+11.70%vsDFTX32.70▼−2.11%ClosedNov 4 '26